The function of GPC5 has yet to be established and studies of its role in tumors have been limited, although the 13q31–32 amplification has been observed in lung carcinomas (12), breast tumors (7), neurological tumors (8), liposarcomas (13) and rhabdomyosarcomas (9). This evidence concerns the gene GPC5 and breast neoplasm.